HS
CCXI

HighVista Strategies’s ChemoCentryx, Inc. CCXI Stock Holding History

HighVista Strategies’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,817
Closed -$657K – 151
2021
Q1 		$657K Sell
12,817
-1,658
-11% -$99.8K 0.49% 48
2020
Q4 		$896K Buy
14,475
+5,080
+54% +$291K 0.57% 37
2020
Q3 		$515K Sell
9,395
-374
-4% -$20.1K 0.38% 46
2020
Q2 		$562K Buy
+9,769
New +$532K 0.47% 16

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HighVista Strategies's CCXI Position: Q2 2021 in Review

HighVista Strategies sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 12,817 shares — an estimated $657K sold.

HighVista Strategies first reported a position in CCXI in Q2 2020 and held it in 4 quarters. The position peaked at $896K in Q4 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

  • HighVista Strategies reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
  • HighVista Strategies sold 12,817 ChemoCentryx, Inc. shares in Q2 2021, an estimated $657K.
  • HighVista Strategies first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 4 quarters.
  • HighVista Strategies's ChemoCentryx, Inc. position peaked at $896K in Q4 2020.
  • 146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on HighVista Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.